Cann Global Limited

ASX:CGB ISIN:AU0000038085

Cann Global Limited ASX:CGBCann Global Limited's (ASX:CGB) primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets.

Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and a management agreement with Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group.

The Group also retains an interest in its existing Bauxite Projects.

    

News

###

24,910 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 159) (Last 30 Days: 642) (Since Published: 24910) 

Company Data

    Headquarters
  • Level 21, 133 Castlereagh Street
    Sydney NSW 2023
    Australia
  • Telephone
  • +61-2-8379-1832 
  • Principal Sector
  • Cannabis and Hemp 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.canngloballimited.com
  • E:
  • media@canngloballimited.com

Company Reports

Latest Videos

Quarterly Report

Social Media